The genetic testing company is addressing the fallout from a 2023 credential stuffing attack. Here's how to protect yourself.

Did you spit in a tube for 23andMe? If so, your genetic data may soon be handed over to a new company — Regeneron. Just four years ago, when 23andMe went public, the company was valued at $6 billion.

The order, which amounted to over $6,000, included 30 tests ...

New York and other states filed a lawsuit seeking to block 23andMe, the bankrupt genetic testing firm, from selling millions of Americans' genetic data to the highest bidder. A total of 28 state ...

23andMe was once a high-flying biotech firm. It collected a trove of DNA data on millions of its customers, and then it went bust. The fate of that data has been at the center of a legal battle over ...

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ offer for the DNA-testing company in a bankruptcy auction.

Twenty-seven states and the District of Columbia have sued the genetic-testing company 23andMe to oppose the sale of DNA data from its customers without their direct consent. The suit, filed Monday in ...

A bankruptcy judge has approved the sale of the insolvent genetics firm 23andMe to a nonprofit run by one of the company's co-founders. The deal effectively avoids the controversial transfer of DNA ...

Editor’s Note: An earlier version of this piece failed to specify that the 23andMe sale is ongoing and is still subject to court approval. We have corrected this ...